SG11201810352XA - New antibacterial compounds - Google Patents
New antibacterial compoundsInfo
- Publication number
- SG11201810352XA SG11201810352XA SG11201810352XA SG11201810352XA SG11201810352XA SG 11201810352X A SG11201810352X A SG 11201810352XA SG 11201810352X A SG11201810352X A SG 11201810352XA SG 11201810352X A SG11201810352X A SG 11201810352XA SG 11201810352X A SG11201810352X A SG 11201810352XA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- roma
- co7d
- pct
- antibacterial compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization 0 11111110111101110111111110101111100111111111110101111111111111111111111111111111 International Bureau (10) International Publication Number (43) International Publication Date .....0\"\"\" WO 2017/211759 Al 14 December 2017 (14.12.2017) WIP0 I PCT (51) International Patent Classification: CO7D 491/04 (2006.01) CO7D 493/04 (2006.01) TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). CO7D 471/04 (2006.01) A61K 31/4985 (2006.01) C07D 401/14 (2006.01) A61K 31/436 (2006.01) Published: C07D 498/04 (2006.01) A61P 31/04 (2006.01) — with international search report (Art. 21(3)) CO7D 513/04 (2006.01) (21) International Application Number: PCT/EP2017/063600 (22) International Filing Date: 05 June 2017 (05.06.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 16173550.1 08 June 2016 (08.06.2016) EP (71) Applicant: AZIENDE CHIMICHE RIUNITE AN- GELINI FRANCESCO A.C.R.A.F. S.P.A. [IT/IT]; Viale Amelia, 70, 00181 ROMA (IT). (72) Inventors: OMBRATO, Rosella; Via Abigaille Zanetta, 68, 00143 ROMA (IT). MAGARO', Gabriele; Via IV No- = - vembre, 18, 00072 Ariccia (RM) (IT). GAROFALO, Bar- _ bara; Via Latina, 49, 00179 ROMA (IT). FURLOTTI, Guido; Via Ferdinando Palasciano, 96, 00151 ROMA (IT). =_ = MANGANO, Giorgina; Via Gran Paradiso, 84, 00139 RO- MA (IT). CAPEZZONE DE JOANNON, Alessandra; Pi- azza dei Vespri Siciliani, 7, 00161 ROMA (IT). Agent: COLOMBO, Stefano, Paolo et al.; MARCHI & = (74) _ — PARTNERS S.r.1., Via Vittor Pisani, 13, 20124 Milano (IT). = Designated States (unless otherwise indicated, for every = (81) = kind of national protection available): AE, AG, AL, AM, = = AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, = CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, = DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, = = MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, = — PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, = SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, — TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. = Designated States (unless otherwise indicated, for every (84) kind of regional protection available): ARIPO (BW, GH, = 1-1 CT ir) GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, IN MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, 1-1 1-1 ei IN 1-1 (54) Title: NEW ANTIBACTERIAL COMPOUNDS 0 ei (57) : The present invention relates to novel antibacterial compounds, pharmaceutical compositions containing them and their 0 use as antimicrobials.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16173550 | 2016-06-08 | ||
| PCT/EP2017/063600 WO2017211759A1 (en) | 2016-06-08 | 2017-06-05 | New antibacterial compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201810352XA true SG11201810352XA (en) | 2018-12-28 |
Family
ID=56116327
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201810352XA SG11201810352XA (en) | 2016-06-08 | 2017-06-05 | New antibacterial compounds |
| SG11201810389XA SG11201810389XA (en) | 2016-06-08 | 2017-06-05 | New antibacterial compounds |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201810389XA SG11201810389XA (en) | 2016-06-08 | 2017-06-05 | New antibacterial compounds |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US10633366B2 (en) |
| EP (2) | EP3468975B1 (en) |
| JP (2) | JP2019517546A (en) |
| KR (2) | KR20190019083A (en) |
| CN (2) | CN109790157A (en) |
| AR (2) | AR108777A1 (en) |
| AU (2) | AU2017276626A1 (en) |
| BR (2) | BR112018075334A2 (en) |
| CA (2) | CA3025624A1 (en) |
| CY (1) | CY1123194T1 (en) |
| DK (1) | DK3468975T3 (en) |
| EA (2) | EA201892822A1 (en) |
| ES (1) | ES2802233T3 (en) |
| HR (1) | HRP20200894T1 (en) |
| HU (1) | HUE049547T2 (en) |
| IL (2) | IL263283A (en) |
| LT (1) | LT3468975T (en) |
| MA (1) | MA45221A (en) |
| MD (1) | MD3468975T2 (en) |
| ME (1) | ME03738B (en) |
| MX (2) | MX2018015125A (en) |
| PL (1) | PL3468975T3 (en) |
| PT (1) | PT3468975T (en) |
| RS (1) | RS60511B1 (en) |
| SG (2) | SG11201810352XA (en) |
| SI (1) | SI3468975T1 (en) |
| WO (2) | WO2017211759A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3468975B1 (en) * | 2016-06-08 | 2020-04-01 | Aziende Chimiche Riunite Angelini Francesco A.C.R. | New antibacterial compounds |
| WO2022109360A1 (en) | 2020-11-23 | 2022-05-27 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| US11970502B2 (en) | 2021-05-04 | 2024-04-30 | Enanta Pharmaceuticals, Inc. | Macrocyclic antiviral agents |
| CN113698412A (en) * | 2021-09-01 | 2021-11-26 | 临沂大学 | Coumarin [4,3-b ] pyrrole derivative and synthesis method and application thereof |
| US11912714B2 (en) | 2021-11-12 | 2024-02-27 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| WO2023086400A1 (en) | 2021-11-12 | 2023-05-19 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| WO2023086350A1 (en) | 2021-11-12 | 2023-05-19 | Enanta Pharmaceuticals, Inc. | Alkyne-containing antiviral agents |
| US11993600B2 (en) | 2021-12-08 | 2024-05-28 | Enanta Pharmaceuticals, Inc. | Saturated spirocyclics as antiviral agents |
| WO2023137007A1 (en) * | 2022-01-11 | 2023-07-20 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of 4,6,7-trifluoro-1h-indole-2-carboxylic acid |
| CN115850672B (en) * | 2022-11-25 | 2024-07-19 | 浙江甬仑聚嘉新材料有限公司 | Liquid crystal polymer and preparation method and application thereof |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2886570B2 (en) * | 1989-09-29 | 1999-04-26 | エーザイ株式会社 | Compounds having fused heterocycle |
| IL101722A (en) * | 1991-05-02 | 1996-05-14 | Wyeth John & Brother Ltd | Piperazine derivatives their preparation and pharmaceutical compositions containing them |
| US5607936A (en) | 1994-09-30 | 1997-03-04 | Merck & Co., Inc. | Substituted aryl piperazines as neurokinin antagonists |
| FR2822154B1 (en) | 2001-03-13 | 2005-10-21 | Aventis Pharma Sa | QUINOLYL PROPYL PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM |
| US6921821B2 (en) * | 2002-06-12 | 2005-07-26 | Abbott Laboratories | Antagonists of melanin concentrating hormone receptor |
| DE102004041163A1 (en) | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | New compounds with antibacterial activity |
| JP5314244B2 (en) * | 2004-10-27 | 2013-10-16 | 富山化学工業株式会社 | Novel nitrogen-containing heterocyclic compounds and salts thereof |
| AU2006230364B2 (en) | 2005-03-31 | 2012-09-13 | Janssen Pharmaceutica N.V. | Bicyclic pyrazole compounds as antibacterial agents |
| US20090131444A1 (en) * | 2005-05-24 | 2009-05-21 | Astrazeneca Ab | Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity |
| MY150958A (en) * | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
| JP5398984B2 (en) * | 2005-06-24 | 2014-01-29 | 富山化学工業株式会社 | Novel nitrogen-containing heterocyclic compounds and salts thereof |
| CN101346379A (en) * | 2005-10-21 | 2009-01-14 | 葛兰素集团有限公司 | Peri condensed tricyclic compounds useful as antibacterial agents |
| MX2009012117A (en) | 2007-05-09 | 2009-11-23 | Pfizer | Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials. |
| JP5620636B2 (en) * | 2007-11-26 | 2014-11-05 | 富山化学工業株式会社 | Antibacterial agent containing novel heterocyclic compound or salt thereof |
| US20110071155A1 (en) * | 2008-05-23 | 2011-03-24 | Carlos Alemparte-Gallardo | Tricyclic Nitrogen Containing Compounds And Their Use As Antibacterials |
| BRPI0912995A2 (en) | 2008-05-23 | 2015-10-13 | Glaxo Group Ltd | nitrogen-containing tricyclic compounds and their use as antibacterial agents |
| TW201022279A (en) * | 2008-11-14 | 2010-06-16 | Astrazeneca Ab | Chemical compounds |
| US8318940B2 (en) | 2009-01-15 | 2012-11-27 | Glaxo Group Limited | Naphthyridin-2 (1 H)-one compounds useful as antibacterials |
| EP2389376A1 (en) | 2009-01-21 | 2011-11-30 | Basilea Pharmaceutica AG | Novel bicyclic antibiotics |
| WO2012003418A2 (en) | 2010-07-02 | 2012-01-05 | The University Of North Carolina At Chapel Hill | Functionally selective ligands of dopamine d2 receptors |
| WO2012117421A1 (en) * | 2011-03-02 | 2012-09-07 | Orchid Research Laboratories Ltd | Histone deacetylase inhibitors |
| JP2014518267A (en) * | 2011-06-27 | 2014-07-28 | 杏林製薬株式会社 | Bridged bicyclic compounds for the treatment of bacterial infections |
| IN2014CN04126A (en) | 2011-11-08 | 2015-07-10 | Actelion Pharmaceuticals Ltd | |
| CN103958525A (en) | 2011-11-30 | 2014-07-30 | 埃科特莱茵药品有限公司 | 3,7-disubstituted octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one antibiotics |
| CN105218501A (en) * | 2014-07-03 | 2016-01-06 | 南京大学 | Containing the coumarin derivatives of piperazine ring and preparation thereof and application in antibacterials |
| KR20170043603A (en) | 2014-08-22 | 2017-04-21 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection |
| MA41169A (en) * | 2014-12-17 | 2017-10-24 | Acraf | WIDE-SPECTRUM ANTIBACTERIAL COMPOUNDS |
| MA41168A (en) | 2014-12-17 | 2017-10-24 | Acraf | NEW ANTIBACTERIAL COMPOUNDS |
| EP3468975B1 (en) * | 2016-06-08 | 2020-04-01 | Aziende Chimiche Riunite Angelini Francesco A.C.R. | New antibacterial compounds |
-
2017
- 2017-06-05 EP EP17732775.6A patent/EP3468975B1/en active Active
- 2017-06-05 ME MEP-2020-112A patent/ME03738B/en unknown
- 2017-06-05 JP JP2018564240A patent/JP2019517546A/en active Pending
- 2017-06-05 HU HUE17732775A patent/HUE049547T2/en unknown
- 2017-06-05 KR KR1020187036945A patent/KR20190019083A/en not_active Application Discontinuation
- 2017-06-05 LT LTEP17732775.6T patent/LT3468975T/en unknown
- 2017-06-05 EP EP17727595.5A patent/EP3468970A1/en not_active Withdrawn
- 2017-06-05 CA CA3025624A patent/CA3025624A1/en not_active Abandoned
- 2017-06-05 MX MX2018015125A patent/MX2018015125A/en unknown
- 2017-06-05 JP JP2018564236A patent/JP2019517545A/en active Pending
- 2017-06-05 EA EA201892822A patent/EA201892822A1/en unknown
- 2017-06-05 PT PT177327756T patent/PT3468975T/en unknown
- 2017-06-05 BR BR112018075334-3A patent/BR112018075334A2/en not_active IP Right Cessation
- 2017-06-05 AU AU2017276626A patent/AU2017276626A1/en not_active Abandoned
- 2017-06-05 EA EA201892815A patent/EA201892815A1/en unknown
- 2017-06-05 US US16/307,410 patent/US10633366B2/en not_active Expired - Fee Related
- 2017-06-05 KR KR1020187036946A patent/KR20190019084A/en not_active Application Discontinuation
- 2017-06-05 MA MA045221A patent/MA45221A/en unknown
- 2017-06-05 MD MDE20190471T patent/MD3468975T2/en not_active IP Right Cessation
- 2017-06-05 WO PCT/EP2017/063600 patent/WO2017211759A1/en unknown
- 2017-06-05 SG SG11201810352XA patent/SG11201810352XA/en unknown
- 2017-06-05 ES ES17732775T patent/ES2802233T3/en active Active
- 2017-06-05 CA CA3025270A patent/CA3025270A1/en not_active Abandoned
- 2017-06-05 AU AU2017276627A patent/AU2017276627A1/en not_active Abandoned
- 2017-06-05 DK DK17732775.6T patent/DK3468975T3/en active
- 2017-06-05 WO PCT/EP2017/063601 patent/WO2017211760A1/en unknown
- 2017-06-05 PL PL17732775T patent/PL3468975T3/en unknown
- 2017-06-05 RS RS20200735A patent/RS60511B1/en unknown
- 2017-06-05 SI SI201730306T patent/SI3468975T1/en unknown
- 2017-06-05 CN CN201780042649.1A patent/CN109790157A/en active Pending
- 2017-06-05 CN CN201780039687.1A patent/CN109415373A/en active Pending
- 2017-06-05 US US16/307,193 patent/US10640488B2/en not_active Expired - Fee Related
- 2017-06-05 MX MX2018015126A patent/MX2018015126A/en unknown
- 2017-06-05 SG SG11201810389XA patent/SG11201810389XA/en unknown
- 2017-06-05 BR BR112018075297-5A patent/BR112018075297A2/en not_active IP Right Cessation
- 2017-06-07 AR ARP170101554A patent/AR108777A1/en unknown
- 2017-06-07 AR ARP170101555A patent/AR108778A1/en unknown
-
2018
- 2018-11-26 IL IL263283A patent/IL263283A/en unknown
- 2018-11-26 IL IL263285A patent/IL263285A/en unknown
-
2020
- 2020-06-04 HR HRP20200894TT patent/HRP20200894T1/en unknown
- 2020-06-29 CY CY20201100597T patent/CY1123194T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201810352XA (en) | New antibacterial compounds | |
| SG11201900135YA (en) | N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors | |
| SG11201804758QA (en) | Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab | |
| SG11201901390TA (en) | Tetracycline compounds and methods of treatment | |
| SG11201804915RA (en) | Methods for treating huntington's disease | |
| SG11201810579YA (en) | Pyrimidin-2-ylamino-1h-pyrazols as lrrk2 inhibitors for use in the treatment of neurodegenerative disorders | |
| SG11201805300QA (en) | Heterocyclic compounds as immunomodulators | |
| SG11201809559UA (en) | Substituted pyridines as inhibitors of dnmt1 | |
| SG11201909960UA (en) | Methods for improving memory and cognition and for treating memory and cognitive disorders | |
| SG11201908640TA (en) | Pyrrolidinones and a process to prepare them | |
| SG11201408237YA (en) | Compound as wnt signaling inhibitor, composition, and use thereof | |
| SG11201808108XA (en) | Synthesis of indazoles | |
| SG11201909807TA (en) | Methods of manufacturing of niraparib | |
| SG11201806544XA (en) | Compounds and methods of treating rna-mediated diseases | |
| SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
| SG11201906222WA (en) | Jak1 selective inhibitors | |
| SG11201804223TA (en) | OCTAHYDROPYRROLO [3, 4-c] PYRROLE DERIVATIVES AND USES THEREOF | |
| SG11201907356SA (en) | Piperidine-substituted mnk inhibitors and methods related thereto | |
| SG11201804123VA (en) | Modulators of kv3 channels to treat pain | |
| SG11201809799WA (en) | Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions | |
| SG11201903076QA (en) | Carbamoyl phenylalaninol compounds and uses therof | |
| SG11201808221QA (en) | 1,5-dihydro-4h-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4h-pyrazolo[4,3-c]pyridin-4-ones as pde1 inhibitors | |
| SG11201809537VA (en) | Urea motif containing compounds and derivatives thereof as antibacterial drugs | |
| SG11201900043TA (en) | Antibody formulations | |
| SG11201909841RA (en) | Antitumoral compounds |